细胞内
细胞内寄生虫
抗菌肽
抗菌剂
巨噬细胞
抗生素
免疫系统
细胞外
微生物学
生物
药物输送
化学
细胞生物学
免疫学
生物化学
体外
有机化学
作者
Valentina Nieto Marín,Danieli Fernanda Buccini,Marlon Henrique Cardoso,Jorge W. Arboleda,Octávio Luiz Franco
标识
DOI:10.1016/j.drudis.2022.103444
摘要
Macrophage intracellular infections are difficult to treat because conventional antibiotics tend to have poor penetration of mammalian cells. As a consequence, the immune response is affected and bacteria remain protected inside macrophages. The use of antimicrobial peptides (AMPs) is one of the alternatives developed as new treatments because of their broad spectrum of action. To improve drug delivery into the intracellular space, extracellular vesicles (EVs) have emerged as an innovative strategy for drug delivery. In particular, apoptotic bodies (ApoBDs) are EVs that exhibit attraction to macrophages, which makes them a promising means of improving AMP delivery to treat macrophage intracellular infections. Here, we review important aspects that should be taken into account when developing ApoBD-AMP conjugates.
科研通智能强力驱动
Strongly Powered by AbleSci AI